|

Evaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Integrity and Function, as Well as on Physical Function and Activity in Older Adults.

RECRUITINGSponsored by Robert Bosch Medical Center
Actively Recruiting
SponsorRobert Bosch Medical Center
Started2025-02-01
Est. completion2026-12
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The hypothesis is that renal function will improve following tricuspid valve intervention. A reduction in renal biomarkers is also expected. Furthermore, based on previous assessments, it is anticipated that there will be an improvement in volume status (reduced edema), symptom burden, and physical capacity in patients. Additionally, the study will assess the impact of the intervention on functional parameters such as motor capacity, physical activity, performance of activities of daily living, and ultimately, participation and quality of life.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Severe symptomatic tricuspid valve insufficiency and referral for TriClip/TricValve screening
* Completed 18th year of life
* Ability to consent
* Able to walk short distances with aids

Exclusion Criteria:

* Dialysis-dependent/terminal kidney disease
* Inability to comply with study-associated assessments (e.g., existing dementia)
* Severe anemia (Hb \<7 g/dl)
* Tricuspid valve intervention with palliative intent and likely imminent death
* Lack of consent

Conditions5

Cardio-Renal SyndromeFrailtyHeart DiseaseTricuspid RegurgitationTricuspid Valve Insufficiency

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.